![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.05 | 5.80 | 6.30 | 6.05 | 6.05 | 6.05 | 109,127 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -5.93 | 36.31M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/9/2021 21:07 | Retirementfund. Is that all you have to say to answer QuePassa’s detailed blog. Log off pal and go back o bed. | ![]() b00mb0y | |
08/9/2021 21:07 | It’s pretty normal quepassa for a company developing a lot of new class leading products not to be profitable. The various products they have developed so far will produce a small profit this financial year. Meanwhile on the side they have developed the biological pathogen detector whilst generating that small profit for the year. Here are some other facts... Order book covers 75 per cent of revenue estimates for 2021/22 financial year. £20m worth of nuclear sector revenue in active procurement that could be delivered this year. Estimated turnover of £15m this year. House broker Cenkos Securities expects gross margins to rise from 48 to 52 per cent, so with the benefit of a relatively fixed cost base last year’s Covid-19 impacted cash loss of £1.7m is forecast to produce a small adjusted cash profit. Hill at Equity Development values the annual global market for the biological threat detection devices at £500m. | ![]() aqc888 | |
08/9/2021 21:02 | @dixter. Thought you had filtered me. “ Just a sample. So what part of that is not informed and relevant information that could provide significant tailwind to the company that we are invested in?” “Could” is a little bit like “if”. hmmm Are you gambling on the “could’s | ![]() b00mb0y | |
08/9/2021 20:56 | AQC. Your post 5092, along with nearly all your posts have been interesting to read and inline with my views in the main. However, this is now becoming a bit ridiculous (and I don’t mean you or your posts) to say the least. There’s no need here to reiterate over everything but all positive posts about KMK on this site have become nothing but massive ramping. In all those posts (ramping posts) there is the word “if” and they’re always massive IF’s. This is not meant as a jibe to you but to all the pathetic ramping that’s being written here. As I said earlier, I’m gambling on the massive IF’s. Good luck! | ![]() b00mb0y | |
08/9/2021 20:52 | What is the brokers forecast for next year. I suspect this is more important than the last 7 years. All in my opinion. | ![]() retirementfund | |
08/9/2021 20:35 | oh I do apologise if you feel my posts are lacking substance. I hope this one of mine from earlier this year on 6th April 2021 (post 4244) helps rectify the situation. Perhaps you weren't on the board at the time or missed it. "Using figures from Equity Development (7/10/20), this is Kromek's seven year performance. Rounded by me to nearest half-million. 1. TURNOVER FIGURES. 2014 £6m 2015 £8m 2016 £8.5m 2017 £9m 2018 £12m 2019 £14.5m 2020 £13m These TURNOVER figures include PRODUCT and OTHER. I assume (but am not certain) that OTHER includes/means grants and research funding. For example, in 2016 OTHER was £3m. In 2019 OTHER was £2.5m TURNOVER total for last 7 years is £71 million. 2. PROFIT BEFORE TAX - ADJUSTED 2014 -£4.5m LOSS 2015 -£3m LOSS 2016 -£4m LOSS 2017 -£4m LOSS 2018 -£2.5m LOSS 2019 -£1.5m LOSS 2020 -£4m LOSS LOSS BEFORE TAX (ADJUSTED) for last seven years is £23.5 million. 3. EQUITY RAISING SINCE IPO 30/7/15 £11million 25/1/17 £21million 12/2/19 £21million 12/2/21 £13million They had raised £53m by end 2020. And the new 2021 Placing, brings total to £66m. A great deal of shareholder dilution. 4. SUMMARY. SEVEN YEARS TURNOVER £71m LOSS £23.5m EQUITY RAISINGS £53m (+ another £13m in 2021) Where does so much money go? With so many positive messages and so many sure-fire guaranteed, copper-bottomed, game-changer, cutting-edge, state-of-the-art and innovative whizzbang new product initiatives, mostly announced to piggy-back off the latest global scare (nuclear detection, airport security, medical imaging, ventilators ,covid), why does this company still make such resolute losses? The Easter weekend marked the 7th. anniversary of the infamous 4/4/14 RNS announcement of the seven year up to $159million CZT-based detection modules contract in China. You see, if you add together ALL Kromek's TURNOVER for the last seven years, the whole lot doesn't come anywhere close to what that ONE SINGLE CONTRACT was meant to bring in. ALL IMO. DYOR. QP " ALL IMO. DYOR. QP | ![]() quepassa | |
08/9/2021 20:15 | Fevered hype?? If you look back at the posts that you are referring to they reference articles or news that's relevant to the field that Kromeks operates.Examples Millions of dollars into US bio detection and early warning.Reports of calls for government to protect schools with bio detection.Just a sample. So what part of that is not informed and relevant information that could provide significant tailwind to the company that we are invested in?It informs other holders on the general sentiment and enviroment that Kromek operates. How they interpret that information is for them. So less of your fevered hype pish. I'm yet to see what if any you and that other boom boy fella offer ,other than glib and idle comments about mismanagement.As many have said, contrary views are welcome and needed for balance. If they have any substance or logic.....I'm still waiting to see any from both of you. | dexter1612 | |
08/9/2021 19:45 | Losing faith? Well any AIM company boomboy is slightly off-piste with higher risks and requires faith. They also come with higher rewards, navigating your way through the limited information is what makes these forums more interesting. I think it’s fair to say the unknowns around Kromek are what is causing the irrational exuberance and fear, with the share price surging and falling every few months. As I always say regarding Kromek, the management seem a little poor. But what we’re all here for is the potential scientific achievements of its scientists in developing the biological pathogen detector, which will be largely patented and years ahead of rivals in an area which is of huge importance to many nations and institutions around the world at the moment (bio-terrorism & pandemic). If Kromek achieves what we’re hoping for it will have a substantial economic moat around its biological pathogen detector. When losing faith you’ve got to remember the track record of Kromeks scientists, which are first class, from their leading medical scanners, leading award winning security x-ray scanners & leading radiation detectors. Kromeks scientists clearly have the ability to produce first class products and if they manage to pull off this biological pathogen detector it’s going to be huge. | ![]() aqc888 | |
08/9/2021 17:52 | b00mb0y not a chance your the one spouting unresearched tripe. Happy to see how it plays out I am very comfortable with my investment and level of research. All in my opinion | ![]() retirementfund | |
08/9/2021 17:26 | so no news then about the covid sniffer thingamajig. doesn't surprise me despite all the fevered hype from multiple posters over the last several weeks. Post 5086 is a bull's-eye. all imo. dyor. qp | ![]() quepassa | |
08/9/2021 17:08 | Oh, by the way, retirementfund. What’s your researched opinion on KMK then. Let’s have it please. | ![]() b00mb0y | |
08/9/2021 16:42 | You could well lose your retirement funding here. I hope you don’t. Is this your first post? Please go back to school and learn to write. | ![]() b00mb0y | |
08/9/2021 16:39 | b00mb0y I must admit if nothing else you add comedy value. I suspect if you a capable go away research Kmk and then come back as you as currently your not really credible. All in my opinion | ![]() retirementfund | |
08/9/2021 16:31 | Aqc…… “I’m satisfied with my holding as Kromek are valued at 24p by equity development without the detector.” That means jack sh1t. The share price and the market tells us otherwise. “Seems like there may well be no news on the biological pathogen detector till the end of the year” and yet we were told “in the coming days” by Arnab in March. (Promises,promises) “ Even if the biological pathogen detector doesn’t work you’re only going to make modest losses, if any. It sounds to me like you are also losing faith, Aqc. Fruitloops “ Barring a major upset like a shareholder rebellion, AGMs are rarely of much consequence.” then why was everyone waiting for today and blogging about it with eagerness? Deedledee “ Can anyone summarise the AGM outcome? Share price has dipped. Why?” Because faith has all but totally gone! This share is now a massive gamble. If (a big IF) it comes good then great but a massive gamble! I’m gambling on the Big IF! | ![]() b00mb0y | |
08/9/2021 15:39 | nevertheless its disappointing! mind you, the mkts are red everywhere! | ![]() abbynat | |
08/9/2021 13:47 | Investors are probably a bit unnerved by the lack of information regarding the trials and quite a lot of unknowns regarding the detector. Not much definitive information seems to be released, I’d suspect the share price will continue to drift lower and stay between 15-19p. I’m satisfied with my holding as Kromek are valued at 24p by equity development without the detector. The rest of the business should perform better than it has for years due to the increased nuclear spending due to rise in instability in Afghanistan and the huge rise in the U.K. government nuclear spending previously mentioned. The medical scanner business is also performing better than it has in years. Even if the biological pathogen detector doesn’t work you’re only going to make modest losses, if any. The upside if the detector does work is huge however. Seems like there may well be no news on the biological pathogen detector till the end of the year | ![]() aqc888 | |
08/9/2021 13:32 | The answers I got from the FD were very positive on barriers to entry for the bio- threat machines, patent protection and the two year head start on competitors who can’t test in automated real time at present. As you astutely observed AQ, the answer to when the bio-threat are commercially available seems to have lengthened from this calendar year to this fiscal year. I’d say that means first qtr next year. A patient hold for me and it is one of those stocks where patience is needed. I’d just ignore the slightly inane posts that shed more heat than light on the prospects. | ![]() nick2412 | |
08/9/2021 13:20 | Barring a major upset like a shareholder rebellion, AGMs are rarely of much consequence. | fruitloops101 | |
08/9/2021 12:47 | Can anyone summarise the AGM outcome? Share price has dipped. Why? | deedledee | |
08/9/2021 12:43 | Is Quepassa for real !! bizarre … | strategicinvestor2 | |
08/9/2021 12:41 | Quepassa, the answer is a big fat zero. The same as all the other before mentioned companies, for the before mentioned reasons. The only thing I agree with you about is your ‘yawn’ comment | ![]() aqc888 | |
08/9/2021 12:35 | Yawn. We are talking about GLOBAL SALES - sales away from the UK- and there you have no legs to stand on | ![]() quepassa | |
08/9/2021 12:23 | Ford, RR & Kromek all were involved in the before mentioned U.K. ventilator challenge (along with dozens of other institutions). They all produced zero ventilators... | ![]() aqc888 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions